Key result
Catheter ablation fails to reduce major events in octogenarians with atrial fibrillation.
Why the study?
Catheter ablation can improve symptoms and functional status in very elderly patients with atrial fibrillation, but it is uncertain whether baseline symptom status identifies those who will benefit the most.
Does catheter ablation reduce the primary composite endpoint of clinical events or improve 1-year patient-centered outcomes compared to non-ablation management in very elderly (≥80 years) patients with non-valvular atrial fibrillation stratified by baseline symptom status?
Observational (n=703)
Yes
Does catheter ablation reduce the primary composite endpoint of clinical events or improve 1-year patient-centered outcomes compared to non-ablation management in very elderly (≥80 years) patients with non-valvular atrial fibrillation stratified by baseline symptom status?
In patients aged 80 and older with non-valvular atrial fibrillation, catheter ablation did not significantly reduce clinical composite events regardless of baseline symptom status, but was associated with broader 1-year improvements in quality of life, cognitive scores, frailty, and left atrial reverse remodeling among symptomatic patients.
Answers are grounded in this paper and cite their sources.
This registry subgroup analysis should not yet change AF ablation referral in octogenarians; leaves open whether symptom status predicts hard clinical outcomes without randomized trials.
Background Catheter ablation can improve symptoms and functional status in very elderly patients with atrial fibrillation. However, it is uncertain if baseline symptom status can pinpoint those who will benefit the most. Methods This exploratory subgroup analysis examined data from the REHEALTH AF registry, which included patients aged 80 and above with non‐valvular atrial fibrillation. Patients were categorized by baseline symptom status and compared based on treatment strategy: catheter ablation versus non‐ablation management. Results Of 703 patients, 238 were asymptomatic, while 465 were symptomatic. Catheter ablation did not significantly reduce the primary composite endpoint in either asymptomatic (adjusted hazard ratio, 1.39; 95% confidence interval, 0.39–4.92; p = 0.61) or symptomatic patients (adjusted hazard ratio, 0.66; 95% confidence interval, 0.36–1.20; p = 0.17), with no significant interaction between treatment and symptoms. Exploratory analyses indicated ablation was associated with more favorable changes in a wider range of 1‐year patient‐centered measures among symptomatic patients, such as quality of life, self‐rated health, Mini‐Mental State Examination score, frailty distribution, N‐terminal pro–B‐type natriuretic peptide level, and left atrial diameter. In asymptomatic patients, improvements were mainly seen in self‐rated health and N‐terminal pro–B‐type natriuretic peptide level. Conclusions In very elderly patients with atrial fibrillation, baseline symptom status did not identify those with a clear short‐term event reduction following catheter ablation. Nevertheless, exploratory analyses revealed more favorable changes across various patient‐centered measures in symptomatic patients, although formal evidence of effect modification was limited.
No takes yet. Share an insight, caveat, or question.
Hirata et al. (2026) conducted an observational in Non-valvular atrial fibrillation (n=703). Catheter ablation vs. Non-ablation management was evaluated on Composite of stroke, transient ischemic attack, or systemic embolism, other cardiovascular events, clinically relevant non-major bleeding or major bleeding, and all-cause death (in symptomatic patients) (Adjusted HR 0.66, 95% CI 0.36-1.20, p=0.17). Catheter ablation did not reduce the primary composite endpoint in either symptomatic or asymptomatic patients aged ≥80 with atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: